Show simple item record

dc.contributor.authorYilmaz, Yusuf Cem
dc.contributor.authorCeylan, Nihan
dc.contributor.authorCinici, Emine
dc.contributor.authorOzer, Muhammet Derda
dc.contributor.authorEkinci, Dilbade Yildiz
dc.contributor.authorCeylan, Erdinc
dc.contributor.authorKartal, Baki
dc.date.accessioned2021-03-02T21:27:47Z
dc.date.available2021-03-02T21:27:47Z
dc.date.issued2016
dc.identifier.citationCeylan E., Ozer M. D. , Yilmaz Y. C. , Kartal B., Ekinci D. Y. , Cinici E., Ceylan N., "The ocular surface side effects of an anti-psychotic drug, clozapine", CUTANEOUS AND OCULAR TOXICOLOGY, cilt.35, sa.1, ss.62-66, 2016
dc.identifier.issn1556-9527
dc.identifier.otherav_071a839a-62f1-4fad-bcf0-67b085ed4390
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/10635
dc.identifier.urihttps://doi.org/10.3109/15569527.2015.1018387
dc.description.abstractPurpose: The purpose of this study is to investigate the effects of long-term clozapine usage on tear film stability and corneal topographic parameters.Material and methods: The study was conducted between March 2014 and November 2014. Thirty patients who were diagnosed of schizophrenia and have been under clozapine treatment for 2.730.73 years (range 2-4 years) were involved in this study (group 1). Thirty healthy subjects (group 2) who have statistically similar demographic features compared with the group 1, were involved as a control group. Full ophthalmologic examination with biomicroscopy and indirect ophthalmoscopy was applied. Corneal topographic parameters were measured using the Pentacam HR and Schirmer test was done. Statistical analysis of the subjects was evaluated by using SPSS (for Windows version 16.0; SPSS Inc., Chicago, IL) program.Results: K-1 value was measured as 43.39 +/- 0.17D (43-43.50D) and K-2 value was measured as 43.39 +/- 0.06D (43.30-43.50D) in groups 1 and 2, respectively. In groups 1 and 2, K-2 values were noted as 43.86 +/- 0.27D (43.50-44.50D) and 43.72 +/- 0.18D (43.50-44.00D), respectively. Central corneal thickness was found to be 523.93 +/- 15.66 mu m (495-554 mu m) and 550.13 +/- 1.03 mu m (520-580 mu m) in groups 1 and 2, respectively. Corneal apex thickness was 525.86 +/- 15.75 mu m (497-556 mu m) in group 1 and 551.60 +/- 14.99 mu m (521-581 mu m) in group 2. The corneal thickness of thinnest location was 520.93 +/- 15.60 mu m (492-551 mu m) and 548.06 +/- 15.17 mu m (518-578 mu m) in groups 1 and 2, respectively. Corneal volume was determined as 58.13 +/- 3.46mm(3) (52-64mm(3)) in group 1 and 60.73 +/- 3.76mm(3) (54-66mm(3)) in group 2. The Schirmer test showed thichkness of 3.33 +/- 0.72mm (2-4mm) and 13.60 +/- 1.59mm (11-16mm) in groups 1 and 2, respectively. The mean fluorescein break-up time was 5.40 +/- 1.50s (3-8s) and 12.46 +/- 1.40s (10-14s) in groups 1 and 2, respectively. There was a statistically significant difference in the Schirmer test, fluorescein break-up time, central corneal thickness, corneal apex, and the thinnest corneal location thickness between the two groups.Conclusion: Clozapine may induce dry eye syndrome and thus may lead to morphological alterations in corneal parameters through its anticholinergic and antidopaminergic activities. Because of these corneal alterations, one should be aware of evaluating patients having diseases like glaucoma or preoperative selection of corneal refractive surgery candidates.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectToxicology
dc.subjectHealth Sciences
dc.subjectHealth, Toxicology and Mutagenesis
dc.subjectOphthalmology
dc.subjectOptometry
dc.subjectPhysical Sciences
dc.subjectLife Sciences
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectOFTALMOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTOKSİKOLOJİ
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectCerrahi Tıp Bilimleri
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectEczacılık
dc.subjectMeslek Bilimleri
dc.subjectFarmasötik Toksikoloji
dc.titleThe ocular surface side effects of an anti-psychotic drug, clozapine
dc.typeMakale
dc.relation.journalCUTANEOUS AND OCULAR TOXICOLOGY
dc.contributor.departmentErzurum Reg Training & Res Hosp , ,
dc.identifier.volume35
dc.identifier.issue1
dc.identifier.startpage62
dc.identifier.endpage66
dc.contributor.firstauthorID227627


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record